Physician profile
Vanessa Blumer
NPI 1659765089
$2,267.62
in general payments reported to CMS, 2019-2025
8 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $577 · 2022: $107 · 2023: $221 · 2024: $739 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,132 · Travel and Lodging: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.65 |
| Travel and Lodging | $169.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,616.86 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $266.80 | 2024-2025 | Impella |
| Medtronic Vascular, INC. | $259.04 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $29.80 | 2024 | Farxiga |
| Merck Sharp & Dohme LLC | $25.33 | 2024 | Verquvo |
| Boston Scientific Corporation | $23.96 | 2025 | Watchman Access System |
| Recor Medical INC | $23.36 | 2025 | Paradise Ultrasound Renal Denervation System |
| Novo Nordisk INC | $22.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Blumer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.